Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil adjunctive treatment for major depressive disorder
IRCT20180522039784N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of modafinil and sertraline in major depressive disorder (MDD) (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoint: Fatigue severity. Started Sep 2019; status: completed.
02
Drugs
modafinilsertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20180522039784N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180522039784N1.